Kardium is a privately held medical solutions company developing integrated technologies for atrial fibrillation treatment
Kardium is a privately held medical solutions company developing integrated technologies for atrial fibrillation treatment. Its Globe Pulsed Field System combines high-density cardiac mapping and pulsed-field ablation in an all-in-one catheter platform, enabling physicians to tailor therapy to patient anatomy and procedural needs. The system received U.S. FDA approval in 2025.